发明名称 |
PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS |
摘要 |
Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure. |
申请公布号 |
WO2009129454(A3) |
申请公布日期 |
2010.01.28 |
申请号 |
WO2009US40941 |
申请日期 |
2009.04.17 |
申请人 |
CRITICAL CARE DIAGNOSTICS, INC.;SNIDER, JAMES, V.;HEYMAN, EUGENE, R. |
发明人 |
SNIDER, JAMES, V.;HEYMAN, EUGENE, R. |
分类号 |
G01N33/50;C12Q1/68;G01N33/68 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|